EW Edwards Lifesciences Corp

  1. Stocks
  2. Healthcare
  3. NYSE: EW

Price (delayed)

$86.43

Market cap

$51.94B

P/E Ratio

37.42

Dividend/share

N/A

EPS

$2.31

Enterprise value

$51.5B

Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of ...

Highlights
The equity has grown by 15% year-on-year
EW's revenue is up by 12% year-on-year and by 3.2% since the previous quarter
The price to earnings (P/E) is 20% lower than the 5-year quarterly average of 46.5 but 8% higher than the last 4 quarters average of 34.6
EW's quick ratio is up by 11% year-on-year but it is down by 3.3% since the previous quarter
The net income has contracted by 8% YoY
The company's EPS fell by 6% YoY
Sector: Healthcare
Industry: Medical Devices
Website: https://www.edwards.com
Peers: BSX MMSI LMAT ICUI

Key stats

What are the main financial stats of EW
Market
Shares outstanding
601M
Market cap
$51.94B
Enterprise value
$51.5B
Valuations
Price to earnings (P/E)
37.42
Price to book (P/B)
7.88
Price to sales (P/S)
8.73
EV/EBIT
31.81
EV/EBITDA
28.74
EV/Sales
8.58
Earnings
Revenue
$6B
EBIT
$1.62B
EBITDA
$1.79B
Free cash flow
$642.8M
Per share
EPS
$2.31
Free cash flow per share
$1.06
Book value per share
$10.97
Revenue per share
$9.9
TBVPS
$12.66
Balance sheet
Total assets
$9.36B
Total liabilities
$2.64B
Debt
$694.9M
Equity
$6.65B
Working capital
$2.84B
Liquidity
Debt to equity
0.1
Current ratio
3.38
Quick ratio
2.08
Net debt/EBITDA
-0.25
Margins
EBITDA margin
29.8%
Gross margin
77%
Net margin
23.4%
Operating margin
25.1%
Efficiency
Return on assets
15.4%
Return on equity
21.9%
Return on invested capital
28%
Return on capital employed
19.8%
Return on sales
27%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

EW stock price

How has the Edwards Lifesciences stock price performed over time
Intraday
-1.8%
1 week
0.57%
1 month
-7.48%
1 year
-1.12%
YTD
13.35%
QTD
-9.55%

Financial performance

How have Edwards Lifesciences's revenue and profit performed over time
Revenue
$6B
Gross profit
$4.63B
Operating income
$1.51B
Net income
$1.4B
Gross margin
77%
Net margin
23.4%
The company's operating margin fell by 21% YoY and by 6% QoQ
The net margin has contracted by 17% YoY and by 4.9% from the previous quarter
EW's revenue is up by 12% year-on-year and by 3.2% since the previous quarter
The operating income has contracted by 12% YoY and by 3.1% from the previous quarter

Growth

What is Edwards Lifesciences's growth rate over time

Valuation

What is Edwards Lifesciences stock price valuation
EW P/E details
P/E
37.42
P/B
7.88
P/S
8.73
EV/EBIT
31.81
EV/EBITDA
28.74
EV/Sales
8.58
The price to earnings (P/E) is 20% lower than the 5-year quarterly average of 46.5 but 8% higher than the last 4 quarters average of 34.6
The company's EPS fell by 6% YoY
The stock's price to book (P/B) is 25% less than its 5-year quarterly average of 10.5 but 2.3% more than its last 4 quarters average of 7.7
The equity has grown by 15% year-on-year
The P/S is 19% below the 5-year quarterly average of 10.8 but 2.7% above the last 4 quarters average of 8.5
EW's revenue is up by 12% year-on-year and by 3.2% since the previous quarter

Efficiency

How efficient is Edwards Lifesciences business performance
The company's return on sales fell by 19% YoY and by 5% QoQ
Edwards Lifesciences's return on equity has decreased by 14% YoY and by 5% QoQ
EW's return on assets is down by 14% year-on-year and by 4.9% since the previous quarter
The company's return on invested capital fell by 12% YoY and by 3.8% QoQ

Dividends

What is EW's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for EW.

Financial health

How did Edwards Lifesciences financials performed over time
The total assets is up by 13% year-on-year
The company's current ratio rose by 12% YoY and by 3% QoQ
The debt is 90% less than the equity
The company's debt to equity fell by 17% YoY
The equity has grown by 15% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.